Company Filing History:
Years Active: 2003
Title: David J Looney: Innovator in Gene Therapy
Introduction
David J Looney is a prominent inventor based in Encinitas, California. He has made significant contributions to the field of gene therapy, particularly through his innovative work with lentiviral vectors. His research focuses on developing methods to effectively target non-dividing cells, which are crucial in treating various medical conditions.
Latest Patents
David J Looney holds a patent for "Lentiviral nucleic acids and uses thereof." This invention provides non-primate lentiviral vectors, packaging cells, and packaging plasmids based on feline and ungulate retroviruses. The packaging plasmids are specifically designed for expression in human cells, which are also utilized as packaging cells. The vectors developed through this invention are capable of transducing human cells, including those that are difficult to target, such as non-dividing cells of the hematopoietic and nervous system, both in vitro and in vivo. These vectors are suitable for general gene transfer and gene therapy aimed at treating conditions mediated by these non-dividing cells, including cancer and HIV infection. David J Looney has 1 patent to his name.
Career Highlights
David J Looney's career is marked by his dedication to advancing gene therapy techniques. His work has opened new avenues for treating diseases that were previously challenging due to the limitations of existing technologies. He is affiliated with the University of California, where he continues to contribute to research and innovation in the field.
Collaborations
David has collaborated with notable researchers such as Eric M Poeschla and Flossie Wong-Staal. These collaborations have further enriched his work and expanded the impact of his inventions in the scientific community.
Conclusion
David J Looney is a key figure in the field of gene therapy, with a focus on developing innovative solutions for targeting non-dividing cells. His contributions through patents and collaborations have the potential to significantly impact the treatment of serious medical conditions.